Upgrade to SI Premium - Free Trial

Exelixis (EXEL)

52.70 +0.21 (0.40%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26)

Latest Headlines

Form 4 EXELIXIS, INC. For: Jun 01 Filed by: WYSZOMIERSKI JACK L June 3, 2026 6:52 PM - SEC Filing Form 4 EXELIXIS, INC. For: Jun 01 Filed by: Eckhardt Sue Gail June 3, 2026 6:52 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: Eckhardt Sue Gail June 1, 2026 4:16 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: WYSZOMIERSKI JACK L June 1, 2026 4:06 PM - SEC Filing Exelixis reports Cabometyx trial results for neuroendocrine tumors May 30, 2026 10:00 AM - StreetInsider Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026 May 30, 2026 10:00 AM - BizWire Form 4 EXELIXIS, INC. For: May 27 Filed by: PAPADOPOULOS STELIOS May 29, 2026 5:44 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Eckhardt Sue Gail May 29, 2026 5:44 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Heyman Tomas J. May 29, 2026 5:44 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Smith Julie May 29, 2026 5:43 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Beckerle Mary C May 29, 2026 5:43 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Freire Maria C May 29, 2026 5:43 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Oliver Bob May 29, 2026 5:43 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: WYSZOMIERSKI JACK L May 29, 2026 5:43 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: POSTE GEORGE May 29, 2026 5:43 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 27 Filed by: Caligan Partners LP May 29, 2026 4:31 PM - SEC Filing Form 8-K EXELIXIS, INC. For: May 26 May 29, 2026 4:07 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 26 Filed by: Aftab Dana May 28, 2026 6:25 PM - SEC Filing Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in June May 27, 2026 4:05 PM - BizWire Form 144 EXELIXIS, INC. Filed by: Aftab Dana May 26, 2026 4:18 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 20 Filed by: Haley Patrick J. May 22, 2026 5:02 PM - SEC Filing Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types May 21, 2026 5:00 PM - BizWire Form 144 EXELIXIS, INC. Filed by: Haley Patrick J. May 20, 2026 4:31 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 15 Filed by: MORRISSEY MICHAEL May 19, 2026 6:59 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 15 Filed by: Senner Christopher J. May 19, 2026 6:59 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 15 Filed by: Haley Patrick J. May 19, 2026 6:59 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 15 Filed by: Hefti Brenda May 19, 2026 6:58 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 15 Filed by: Aftab Dana May 19, 2026 6:58 PM - SEC Filing Exelixis partners with Merck for colorectal cancer trial May 19, 2026 8:00 AM - StreetInsider Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer May 19, 2026 8:00 AM - BizWire Form 144 EXELIXIS, INC. Filed by: Senner Christopher J. May 18, 2026 4:50 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: Hefti Brenda May 18, 2026 4:28 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: MORRISSEY MICHAEL May 14, 2026 4:31 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 07 Filed by: Freire Maria C May 8, 2026 7:04 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 07 Filed by: Beckerle Mary C May 8, 2026 7:04 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 07 Filed by: POSTE GEORGE May 8, 2026 7:04 PM - SEC Filing Form 4 EXELIXIS, INC. For: May 06 Filed by: MORRISSEY MICHAEL May 8, 2026 7:04 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: Beckerle Mary C May 7, 2026 4:39 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: POSTE GEORGE May 7, 2026 4:37 PM - SEC Filing Form 144 EXELIXIS, INC. Filed by: Freire Maria C May 7, 2026 4:08 PM - SEC Filing Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May May 7, 2026 4:05 PM - BizWire Exelixis (EXEL) PT Raised to $56 at H.C. Wainwright May 7, 2026 7:44 AM - StreetInsider Exelixis (EXEL) PT Raised to $47 at Stifel May 6, 2026 9:14 AM - StreetInsider Exelixis (EXEL) PT Raised to $40 at Wells Fargo May 6, 2026 8:49 AM - StreetInsider Exelixis (EXEL) PT Raised to $55 at TD Cowen May 6, 2026 8:18 AM - StreetInsider Exelixis (EXEL) PT Raised to $50 at Morgan Stanley May 6, 2026 8:14 AM - StreetInsider Exelixis (EXEL) Tops Q1 EPS by 10c, provides guidance May 5, 2026 4:20 PM - StreetInsider Form 10-Q EXELIXIS, INC. For: Apr 03 May 5, 2026 4:12 PM - SEC Filing Form 8-K EXELIXIS, INC. For: May 05 May 5, 2026 4:09 PM - SEC Filing Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update May 5, 2026 4:05 PM - BizWire Form SCHEDULE 13G EXELIXIS, INC. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 6:50 PM - SEC Filing Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 April 21, 2026 4:05 PM - BizWire RBC on Exelixis (EXEL): 'think the stock is fairly valued' April 21, 2026 9:44 AM - StreetInsider Exelixis (EXEL) PT Raised to $45 at Barclays April 20, 2026 4:00 AM - StreetInsider Form DEFA14A EXELIXIS, INC. April 17, 2026 4:14 PM - SEC Filing Form DEFA14A EXELIXIS, INC. April 15, 2026 4:20 PM - SEC Filing Form DEF 14A EXELIXIS, INC. For: May 26 April 15, 2026 4:17 PM - SEC Filing Form SCHEDULE 13G/A EXELIXIS, INC. Filed by: VANGUARD GROUP INC March 26, 2026 6:23 PM - SEC Filing Full Article List